Lectin, Galactoside-Binding, Soluble, 9 (LGALS9) (Middle Region) Peptide
Our Local Distributor
北京 101111
Quick Overview for Lectin, Galactoside-Binding, Soluble, 9 (LGALS9) (Middle Region) Peptide (ABIN8104193)
抗原
宿主
资源
应用范围
-
-
蛋白结构域
- Middle Region
-
原理
- LGALS9 Peptide - middle region
-
序列
- YVVCNTRQNG SWGPEERKTH MPFQKGMPFD LCFLVQSSDF KVMVNGILFV
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
说明
-
This is a synthetic peptide designed for use in combination with anti-LGALS9 Antibody (ARP72264_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
缓冲液
- Lyophilized powder
-
储存条件
- -20 °C
-
储存方法
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- Galectin 9 (LGALS9) (Lectin, Galactoside-Binding, Soluble, 9 (LGALS9))
-
背景
- The galectins are a family of beta-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. LGALS9 is an S-type lectin. It is overexpressed in Hodgkin's disease tissue and might participate in the interaction between the H&RS cells with their surrounding cells and might thus play a role in the pathogenesis of this disease and/or its associated immunodeficiency.
-
分子量
- 35kDa
-
基因ID
- 3965
-
UniProt
- O00182
抗原
-